125 related articles for article (PubMed ID: 31545285)
1. Descending-SHIP2-mediated radiosensitivity enhancement through PI3K/Akt signaling pathway in laryngeal squamous cell carcinoma.
Tang T; Xiao ZY; Shan G; Lei HB
Biomed Pharmacother; 2019 Oct; 118():109392. PubMed ID: 31545285
[TBL] [Abstract][Full Text] [Related]
2. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
Huang S; Jin A
J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
[TBL] [Abstract][Full Text] [Related]
3. Tra2β silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling.
Ni HS; Hu SQ; Chen X; Liu YF; Ni TT; Cheng L
Laryngoscope; 2019 Sep; 129(9):E318-E328. PubMed ID: 30597574
[TBL] [Abstract][Full Text] [Related]
4. Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.
Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM
Oncotarget; 2016 Nov; 7(45):73525-73540. PubMed ID: 27716613
[TBL] [Abstract][Full Text] [Related]
5. [Effect of c-Met inhibitor AMG-102 on radiosensitivity in laryngeal squamous carcinoma cells].
Cao F; Lyu X; Dong KF; Fan C; Zhang JJ; Chen K; Ma BJ; Hou CL; Zhang CH
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):909-917. PubMed ID: 31874548
[No Abstract] [Full Text] [Related]
6. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
[TBL] [Abstract][Full Text] [Related]
7. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway.
Lu B; Di W; Wang H; Ma H; Li J; Zhang Q
Tumour Biol; 2012 Dec; 33(6):2007-17. PubMed ID: 23136087
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma.
Geng J; Liu Y; Jin Y; Tai J; Zhang J; Xiao X; Chu P; Yu Y; Wang SC; Lu J; Han S; Shi J; Guo Y; Ni X
Oncol Rep; 2016 Apr; 35(4):2017-26. PubMed ID: 26883008
[TBL] [Abstract][Full Text] [Related]
10. Scaffold dependent role of the inositol 5'-phosphatase SHIP2, in regulation of oxidative stress induced apoptosis.
Azzi A
Arch Biochem Biophys; 2021 Jan; 697():108667. PubMed ID: 33181128
[TBL] [Abstract][Full Text] [Related]
11. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
[TBL] [Abstract][Full Text] [Related]
12. Dehydrocostus lactone inhibits cell proliferation and induces apoptosis by PI3K/Akt/Bad and ERS signalling pathway in human laryngeal carcinoma.
Zhang R; Hao J; Wu Q; Guo K; Wang C; Zhang WK; Liu W; Wang Q; Yang X
J Cell Mol Med; 2020 Jun; 24(11):6028-6042. PubMed ID: 32319208
[TBL] [Abstract][Full Text] [Related]
13. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
[TBL] [Abstract][Full Text] [Related]
14. [AMG-102 inhibits proliferation and induces apoptosis of laryngeal squamous cell carcinoma cells by regulating c-Met/PI3K/Akt pathway].
Cao F; Lyu X; Dong KF; Fan C; Zhang JJ; Chen K; Zhang Y; Ma BJ; Hou CL; Zhang CH
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):99-104. PubMed ID: 32135642
[No Abstract] [Full Text] [Related]
15. Prognostic value of elevated SHIP2 expression in laryngeal squamous cell carcinoma.
Zhou X; Liu Y; Tan G
Arch Med Res; 2011 Oct; 42(7):589-95. PubMed ID: 22079859
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑195 is associated with regulating the pathophysiologic process of human laryngeal squamous cell carcinoma.
Pang H; Xu X; Dai L; Wang K; Yao X
Mol Med Rep; 2018 Apr; 17(4):5283-5291. PubMed ID: 29393451
[TBL] [Abstract][Full Text] [Related]
17. SHIP2 inhibition alters redox-induced PI3K/AKT and MAP kinase pathways via PTEN over-activation in cervical cancer cells.
Azzi A
FEBS Open Bio; 2020 Oct; 10(10):2191-2205. PubMed ID: 32881386
[TBL] [Abstract][Full Text] [Related]
18. Effect of DJ-1 overexpression on the proliferation, apoptosis, invasion and migration of laryngeal squamous cell carcinoma SNU-46 cells through PI3K/AKT/mTOR.
Wang B; Qin H; Wang Y; Chen W; Luo J; Zhu X; Wen W; Lei W
Oncol Rep; 2014 Sep; 32(3):1108-16. PubMed ID: 24969178
[TBL] [Abstract][Full Text] [Related]
19. Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo.
Luo XM; Xu B; Zhou ML; Bao YY; Zhou SH; Fan J; Lu ZJ
PLoS One; 2015; 10(11):e0143306. PubMed ID: 26600164
[TBL] [Abstract][Full Text] [Related]
20. Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt.
Ye Y; Ge YM; Xiao MM; Guo LM; Li Q; Hao JQ; Da J; Hu WL; Zhang XD; Xu J; Zhang LJ
J Gastroenterol; 2016 Mar; 51(3):230-40. PubMed ID: 26201869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
